About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
2021 KUMC Virtual Multidisciplinary Oncology Review
Videos
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
IO/Chemo Developments in Advanced GE/GEJ Cancer: 1L Nivo/Pembro, Peri-Operative FOLFOX + Pembro in Resectable Disease
By
2021 KUMC Virtual Multidisciplinary Oncology Review
FEATURING
Anwaar Saeed
By
2021 KUMC Virtual Multidisciplinary Oncology Review
FEATURING
Anwaar Saeed
13 views
June 11, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
10:25
Exelixis
Explore the mechanism of Action of a TKI in HCC
Feat.
W. Keiser
Featured Video
19:22
Janssen Oncology
Doc Talk Podcast
Feat.
J. Hamilton,
M. Fabrizio,
M. Taha
Videos
06:40
2021 KUMC Virtual Multidisciplinary Oncology Review
IO/Chemo Developments in Advanced GE/GEJ Cancer: 1L Nivo/Pembro, Per…
Feat.
A. Saeed
05:28
2021 KUMC Virtual Multidisciplinary Oncology Review
IO+VEGF TKI Developments in Advanced GE/GEJ Cancer: Overview of Clin…
Feat.
A. Saeed
09:20
2021 KUMC Virtual Multidisciplinary Oncology Review
Targeted Therapy in Advanced GE/GEJ Cancer: T-DXd, mFOLFOX6+/-1L Bem…
Feat.
A. Saeed
20:29
2021 KUMC Virtual Multidisciplinary Oncology Review
Updates in Musculoskeletal Oncologic Surgery: Pros and Cons, Custom …
Feat.
K. Sweeney
22:15
2021 KUMC Virtual Multidisciplinary Oncology Review
2021 Sarcoma Updates: Surgery in Extremity Sarcomas, Chemo/XRT for S…
Feat.
B. Powers
11:11
2021 KUMC Virtual Multidisciplinary Oncology Review
TaTME in Colon and Rectal Surgery: Comparison to Robotic & Lapar…
Feat.
V. Obias
18:04
2021 KUMC Virtual Multidisciplinary Oncology Review
2021 Updates on Robotics in Colorectal Surgery: Flexrobotic System f…
Feat.
V. Obias
22:43
2021 KUMC Virtual Multidisciplinary Oncology Review
Recent Changes in Surgical Management of CRC: Colon Cancer Triage, O…
Feat.
S. Luka
18:39
2021 KUMC Virtual Multidisciplinary Oncology Review
Interventional Oncology for Colorectal Metastases: Percutaneous Ther…
Feat.
A. Alli
17:05
2021 KUMC Virtual Multidisciplinary Oncology Review
2021 Advances in Neoadjuvant/Adjuvant Therapy for CRC: TNT for LARC,…
Feat.
A. Kasi
05:53
2021 KUMC Virtual Multidisciplinary Oncology Review
mCRC Updates: FOLFOXIRI+Bev for Unresectable Disease, CEND-1+Neoadju…
Feat.
A. Kasi
09:37
2021 KUMC Virtual Multidisciplinary Oncology Review
Updates on dMMR/MSI-H CRC: Survival Data for Pembro & Nivo, Fron…
Feat.
H. Lenz
06:58
2021 KUMC Virtual Multidisciplinary Oncology Review
IO Updates for MSS & HER2 Overexpression CRC: Nivo Alone or in C…
Feat.
H. Lenz
16:09
2021 KUMC Virtual Multidisciplinary Oncology Review
RAS/RAF Mutations and New Approaches in CRC: Onvansertib+Irinotecan …
Feat.
H. Lenz
12:11
2021 KUMC Virtual Multidisciplinary Oncology Review
Updates in Esophageal & GEJ Cancers: Preoperative CRT in EC, Pem…
Feat.
D. Akhavan
20:22
2021 KUMC Virtual Multidisciplinary Oncology Review
Esophagectomy vs. Total Gastrectomy for GEJ Adenocarcinoma: Pros and…
Feat.
M. Al-Kasspooles
18:33
2021 KUMC Virtual Multidisciplinary Oncology Review
2021 RT Updates in Localized, Post-Operative, and Oligometastatic PC…
Feat.
X. Shen
17:00
2021 KUMC Virtual Multidisciplinary Oncology Review
2021 Updates in Surgical Treatment of PC: Diagnosis, MRI in Biopsy, …
Feat.
W. Parker
08:24
2021 KUMC Virtual Multidisciplinary Oncology Review
KUMC Updates on PFS/OS Data in mHSPC: Enzalutamide or Standard 1L Th…
Feat.
R. Parikh
14:33
2021 KUMC Virtual Multidisciplinary Oncology Review
KUMC Updated Data on mCRPC: Cabazitaxel vs. Abiraterone/Enzalutamide…
Feat.
R. Parikh
